Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

被引:1
作者
Zhou, H. [1 ]
Long, B. [2 ]
Yu, Z. [3 ]
Zhu, J. [2 ]
Yang, H. [4 ]
Zhang, W. [3 ]
Guan, X. [5 ]
Zhang, G. [2 ]
Li, L. [2 ]
Luo, C. [2 ]
Cao, H. [2 ]
Zhang, S. [2 ]
Chen, S. [2 ]
He, Q. [2 ]
Gan, S. [2 ]
Zhou, L. [2 ]
Jiang, X. [2 ]
Shi, W.
Huang, Z. [5 ]
Mao, J. [2 ]
Dong, C. [6 ]
Jiao, Z. [2 ]
机构
[1] Gansu Prov Canc Hosp, Dept Abdominal Surg, Lanzhou, Peoples R China
[2] Lanzhou Univ Second Hosp, Dept Gen Surg, Lanzhou, Peoples R China
[3] Lanzhou Univ Second Hosp, Dept Radiol, Lanzhou, Peoples R China
[4] Lanzhou Univ Second Hosp, Cuiying Cent Lab, Lanzhou, Peoples R China
[5] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Peoples R China
[6] Lanzhou Univ Second Hosp, Dept Pathol, Lanzhou, Peoples R China
关键词
D O I
10.1016/j.annonc.2023.04.202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-146
引用
收藏
页码:S66 / S67
页数:2
相关论文
共 50 条
[21]   Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study [J].
Jiang, Haiping ;
Yu, Xiongfei ;
Li, Ning ;
Kong, Mei ;
Ma, Zhimin ;
Zhou, Donghui ;
Wang, Weibin ;
Wang, Haohao ;
Wang, Haiyong ;
He, Kuifeng ;
Li, Zhongqi ;
Lu, Yimin ;
Zhang, Jing ;
Zhao, Kui ;
Zhang, Yafei ;
Xu, Nong ;
Li, Ziran ;
Liu, Ying ;
Wang, Yan ;
Wang, Yisen ;
Teng, Lisong .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
[22]   Perioperative camrelizumab combined with chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: A single-arm, single-center, phase II clinical trial [J].
He, J. ;
Yang, Y. ;
Zhou, S. ;
Zhang, B. ;
Han, Z. ;
Wu, T. ;
Qiao, Q. ;
Yang, H. ;
He, X. ;
Wang, N. .
ANNALS OF ONCOLOGY, 2023, 34 :S1549-S1549
[23]   Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial [J].
Wei, Jia ;
Lu, Xiaofeng ;
Liu, Qin ;
Fu, Yao ;
Liu, Song ;
Li, Lin ;
Liu, Fangcen ;
Fan, Xiangshan ;
Yang, Ju ;
Yang, Yang ;
Zhao, Yang ;
Guan, Wenxian ;
Liu, Baorui .
CANCER MANAGEMENT AND RESEARCH, 2022, 14 :2007-2015
[24]   Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study [J].
Long, Bo ;
Zhou, Huinian ;
Yu, Zeyuan ;
Zhu, Junmin ;
Yang, Hanteng ;
Huang, Zeping ;
Wei, Dengwen ;
Chen, Shigong ;
Yang, Xiaojun ;
Zhao, Xiaoning ;
Zhang, Wenjuan ;
Yan, Hong ;
Guan, Xiaoying ;
Li, Long ;
Zhang, Gengyuan ;
Yu, Hongwei ;
Che, Shengfu ;
Gao, Zhongti ;
Jiang, Xiangyan ;
Luo, Changjiang ;
Mao, Jie ;
Zhao, Da ;
Li, Yumin ;
Jiang, Zebin ;
Jiao, Zuoyi .
MED, 2025, 6 (03)
[25]   Fruquintinib combined with sintilimab and SOX as conversion therapy for unresectable locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, phase 2 clinical trial. [J].
Ma, Fei ;
Luo, Suxia ;
Zhang, Bin ;
Ma, Qi ;
Ji, Sheqing ;
Zhang, Zhandong ;
Zhang, Yonglei ;
Yang, Wei ;
Peng, Liangqun ;
Guo, Dandan ;
Ren, Jinjun ;
Zhang, Yuan ;
Su, Yueyue ;
Li, Jing ;
Liu, Wentao ;
Huang, Jinxi ;
Yuan, Weiwei .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[26]   Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial [J].
Shi, Jinming ;
Li, Ning ;
Tang, Yuan ;
Jiang, Liming ;
Yang, Lin ;
Wang, Shulian ;
Song, Yongwen ;
Liu, Yueping ;
Fang, Hui ;
Lu, Ningning ;
Qi, Shunan ;
Chen, Bo ;
Li, Ziyu ;
Liu, Shixin ;
Wang, Jun ;
Wang, Wenling ;
Zhu, Suyu ;
Yang, Jialin ;
Li, Yexiong ;
Zhao, Dongbing ;
Jin, Jing .
BMC GASTROENTEROLOGY, 2022, 22 (01)
[27]   Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial [J].
Jinming Shi ;
Ning Li ;
Yuan Tang ;
Liming Jiang ;
Lin Yang ;
Shulian Wang ;
Yongwen Song ;
Yueping Liu ;
Hui Fang ;
Ningning Lu ;
Shunan Qi ;
Bo Chen ;
Ziyu Li ;
Shixin Liu ;
Jun Wang ;
Wenling Wang ;
Suyu Zhu ;
Jialin Yang ;
Yexiong Li ;
Dongbing Zhao ;
Jing Jin .
BMC Gastroenterology, 22
[28]   Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy [J].
Min, L. Z. ;
Liu, N. ;
Zhou, Y. ;
Niu, Z. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S1106-S1106
[29]   Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety. [J].
Liu, Ying ;
Han, Guangsen ;
Li, Hongle ;
Zhao, Yuzhou ;
Li, Zhi ;
Zhuang, Jing ;
Wang, Gangcheng ;
Li, Baodong ;
Wang, Jinbang ;
Li, Zhimeng ;
Xia, Qingxin ;
Zhang, Chengjuan ;
Yu, Juan ;
Li, Ke ;
Xu, Shuning ;
Qiao, Lei ;
Kuang, Gaizhen ;
Li, Danyang .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[30]   SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial [J].
Zhang, Peng-Fei ;
Chen, Ye ;
Li, Wen-Ke ;
Luo, Zhu-Mei ;
Chen, Ji ;
Qian, Kun ;
Chen, Xiao-Dong ;
Wang, Mo-Jin ;
Liu, Ming .
FRONTIERS IN IMMUNOLOGY, 2024, 15